Reported Jul 20, 2016 · Terminated
HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY
Medaus, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Medaus, Inc. · 6801 Cahaba Valley Rd Ste 116 · Birmingham, AL · 35242-9609
Is this the product you have?
- HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY
- Lot codes and dates
10 of 10 products
Products covered by this recall # Product as published 1 160202-12, BUD: 07/11/16 2 Lot #: 160204-10, BUD: 07/11/16 3 Lot #: 160210-70, BUD: 07/11/16 4 Lot #: 160215-11, BUD: 07/11/16 5 Lot #: 160222-17, BUD: 07/11/16 6 Lot #: 160223-64, BUD: 07/11/16 7 Lot #: 160224-67, BUD: 07/11/16 8 Lot #: 160307-28, BUD: 07/11/16 9 Lot #: 160308-1, BUD: 07/11/16 10 Lot #: 160309-3, BUD: 07/11/16 - Amount recalled
- 210 mL in Vials
This recall covers 88 products
The agency filed one notice per product. You are reading one of them; the other 87 are below.
75 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Medaus, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.